Sort   by:  
 Page size 
GenomicsModulation of the human pancreatic ductal adenocarcinoma immune microenvironment by stereotactic body radiotherapy
Modulation of the human pancreatic ductal adenocarcinoma immune microenvironment by stereotactic body radiotherapy
PRJNA768494 | ENA
ProteomicsClinical efficacy and biomarker analysis of stereotactic body radiotherapy combined with sintilimab and a bevacizumab biosimilar in anti-PD-1 refractory hepatocellular carcinoma
Immune checkpoint inhibitor (ICI) resistance in advanced hepatocellular carcinoma (HCC)poses a major therapeutic challenge. Here, we report a phase 2 trial evaluating stereotactic bodyradiotherapy (SBRT) combined with the anti-PD-1 antibody sintilimab and bevacizumabbiosimilar (lBI305) to re-sensiti...
ORGANISM(S): Homo sapiens (Human) 
2025-10-15 | PAD000004 | Pride
Sintilimab Bevacizumab biosimilar Anti-pd-1 refractory hepatocellular carcinoma Biomarkers of efficacy Stereotactic body radiotherapy 
GenomicsA Prospective Pilot Study of Urine microRNA as a Biomarker of Urinary Toxicity Following MRI-Guided Prostate Stereotactic Body Radiotherapy
A Prospective Pilot Study of Urine microRNA as a Biomarker of Urinary Toxicity Following MRI-Guided Prostate Stereotactic Body Radiotherapy
PRJNA1282697 | ENA
OtherStereotactic body radiotherapy is effective in modifying the tumor genome and tumor immune microenvironment in non-small cell lung cancer or lung metastatic carcinoma [exome-seq]
Background and purpose: To directly reveal the change in genome mutation, RNA transcript of tumor cells, and tumor microenvironment (TME) after stereotactic body radiotherapy (SBRT) in paired human lung tumor specimens.
ORGANISM(S): Homo sapiens 
2020-12-10 | GSE162944 | GEO
TranscriptomicsStereotactic body radiotherapy is effective in modifying the tumor genome and tumor immune microenvironment in non-small cell lung cancer or lung metastatic carcinoma [RNA-seq]
Background and purpose: To directly reveal the change in genome mutation, RNA transcript of tumor cells, and tumor microenvironment (TME) after stereotactic body radiotherapy (SBRT) in paired human lung tumor specimens.
ORGANISM(S): Homo sapiens 
2020-12-10 | GSE162945 | GEO
TranscriptomicsModulation of the human pancreatic ductal adenocarcinoma immune microenvironment by stereotactic body radiotherapy
Purpose: Stereotactic body radiotherapy (SBRT) is an emerging treatment modality for pancreatic ductal adenocarcinoma (PDAC) that can effectively prime cytotoxic T cells by inducing immunogenic tumor cell death in preclinical models. SBRT effects on human PDAC have yet to be thoroughly investigated,...
ORGANISM(S): Homo sapiens 
2021-10-08 | GSE185311 | GEO
UnknownStereotactic Body Radiotherapy for Primary Prostate Cancer.
Not available
S-EPMC6069023 | biostudies-literature
UnknownDosimetric Comparison and Evaluation of 4 Stereotactic Body Radiotherapy Techniques for the Treatment of Prostate Cancer.
Not available
S-EPMC5616037 | biostudies-literature
UnknownPractical patterns for stereotactic body radiotherapy to hepatocellular carcinoma in Korea: a survey of the Korean Stereotactic Radiosurgery Group.
Not available
S-EPMC4886133 | biostudies-literature
UnknownPredicting the benefit of stereotactic body radiotherapy of colorectal cancer metastases
Not available
S-EPMC9356237 | biostudies-literature
Sort   by:  
 Page size